ArticleHaematologica2026

ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study.

Gil Fridberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.